Spin-outs, Start-ups, Sector investment
Spliceor receives investment from the Cell and Gene Therapy Catapult as part of the Cross-Catapult Investment PilotStanding out: Defining the market for your new ATMP assetAn effective team strategy for cell and gene therapy venturesRisky Business: How to de-risk your ATMP asset to attract investment